Citigroup raises Ducommun price target to $216
Citigroup analyst John Godyn maintains a Buy rating on Ducommun and raises the price target to $216 from $167, signaling a positive outlook for the stock.
*this image is generated using AI for illustrative purposes only.
Citigroup analyst John Godyn has maintained a Buy rating on Ducommun and raised the price target to $216 from the previous $167. The revised target indicates a more optimistic outlook for the company's stock performance.
The adjustment follows a review of Ducommun's market position and financial prospects. The new price target suggests a significant upside from current levels based on the analyst's valuation model.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $167 |
| New Price Target | $216 |
The decision to maintain the Buy rating alongside the higher price target underscores the analyst's conviction in Ducommun's growth trajectory. Investors will likely monitor the stock's movement towards the revised target in the coming sessions.
What specific market trends or financial metrics drove the significant increase in Ducommun's price target?
How might Ducommun's competitors react to this revised outlook, and could it influence sector-wide valuations?
What are the key risks or challenges Ducommun could face in achieving the new $216 price target?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
